Tablets India Pharma
- All
- News
-
Alembic Pharma Gets Regulator's Approval To Market Antidepressant Drug In US
Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration to market Brexpiprazole tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures
Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures.
-
Glenmark Pharmaceuticals Gets Final US Approval For Lacosamide Tablet
Homegrown pharma major Glenmark Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic Lacosamide tablet, indicated for prevention and control of seizures.
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
Zenara Pharma Receives Nod To Sell Covid-19 Drug Favipiravir
Zenara Pharma: The Hyderabad-based company has received an approval to sell Favipiravir tablets for treating patients with mild to moderate symptoms of Covid-19.
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
-
Indian-American's Pharma Firm Donates 3.4 Million Hydroxychloroquine Tablets
An Indian American-owned pharma firm has pledged to donate 3.4 million Hydroxychloroquine Sulphate tablets to some of the key COVID-19 battleground states, including New York and Louisiana, joining the war against the dreaded coronavirus which by Tuesday had taken lives of more than 12,800 people in the US alone.
-
Saridon Exempted From List Of Banned Medicines By Top Court, Says Company
Pharma major Piramal Enterprises on Thursday said Saridon, its pain relief tablet, has been exempted from the list of banned fixed dose combinations (FDCs) by the Supreme Court.
-
Ajanta Pharma Launches Pain Relief Tablets In US
Shares of Ajanta Pharma were trading 0.35 per cent higher at Rs 1,197.10 on the BSE.
-
Lupin Recalls Oral Contraceptive From US Market
According to the US drug watchdog - USFDA - as many as 24,652 tablets are being recalled.
-
Glenmark Pharma Gets USFDA Nod For Hypertension Medicine
According to IMS Health sales data for the 12 months to May 2017, Azor tablets achieved annual sales of approximately $211.6 million, Glenmark said.
-
Dr Reddy's, Aurobindo Pharma Recall Some Drugs From US Market, Says Regulator
Dr Reddy's is recalling Olanzapine tablets USP of 2.5 mg while Aurobindo is recalling Pantoprazole Sodium for Injection, 40mg per vial from the market, the notification issued by the US regulator said.
-
Sun Pharma Recalls 2.7 Lakh Bottles Of Antidepressant, Says US Regulator
The recall is being initiated by Sun Pharmaceutical Industries Inc for 2,71,212 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strengths of 150 mg and 200 mg, the FDA said.
-
Lupin Gets USFDA Nod For Generic Anti-Depressant Tablets
Quoting IMS MAT September 2016 data, Lupin said, Paxil CR tablets had US sales of $127.7 million.
-
Alembic Pharma Gets Regulator's Approval To Market Antidepressant Drug In US
Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration to market Brexpiprazole tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures
Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures.
-
Glenmark Pharmaceuticals Gets Final US Approval For Lacosamide Tablet
Homegrown pharma major Glenmark Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic Lacosamide tablet, indicated for prevention and control of seizures.
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
Zenara Pharma Receives Nod To Sell Covid-19 Drug Favipiravir
Zenara Pharma: The Hyderabad-based company has received an approval to sell Favipiravir tablets for treating patients with mild to moderate symptoms of Covid-19.
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
-
Indian-American's Pharma Firm Donates 3.4 Million Hydroxychloroquine Tablets
An Indian American-owned pharma firm has pledged to donate 3.4 million Hydroxychloroquine Sulphate tablets to some of the key COVID-19 battleground states, including New York and Louisiana, joining the war against the dreaded coronavirus which by Tuesday had taken lives of more than 12,800 people in the US alone.
-
Saridon Exempted From List Of Banned Medicines By Top Court, Says Company
Pharma major Piramal Enterprises on Thursday said Saridon, its pain relief tablet, has been exempted from the list of banned fixed dose combinations (FDCs) by the Supreme Court.
-
Ajanta Pharma Launches Pain Relief Tablets In US
Shares of Ajanta Pharma were trading 0.35 per cent higher at Rs 1,197.10 on the BSE.
-
Lupin Recalls Oral Contraceptive From US Market
According to the US drug watchdog - USFDA - as many as 24,652 tablets are being recalled.
-
Glenmark Pharma Gets USFDA Nod For Hypertension Medicine
According to IMS Health sales data for the 12 months to May 2017, Azor tablets achieved annual sales of approximately $211.6 million, Glenmark said.
-
Dr Reddy's, Aurobindo Pharma Recall Some Drugs From US Market, Says Regulator
Dr Reddy's is recalling Olanzapine tablets USP of 2.5 mg while Aurobindo is recalling Pantoprazole Sodium for Injection, 40mg per vial from the market, the notification issued by the US regulator said.
-
Sun Pharma Recalls 2.7 Lakh Bottles Of Antidepressant, Says US Regulator
The recall is being initiated by Sun Pharmaceutical Industries Inc for 2,71,212 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strengths of 150 mg and 200 mg, the FDA said.
-
Lupin Gets USFDA Nod For Generic Anti-Depressant Tablets
Quoting IMS MAT September 2016 data, Lupin said, Paxil CR tablets had US sales of $127.7 million.
